This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Mind drugs spark debate over use in schools and society
A prolonged debate on mind altering drugs examines rising prescriptions by qualified physicians, potential overuse, addiction risk, and the role of advertising. Experts cite growing sales, regulatory steps by FDA, and campaigns to curb illicit use while noting benefits for severe mental illness and anxiety relief.
MENTIONED IN THIS ARTICLE
New York
Donald Louria
Sidney Cohen
John Kramer
Soloman H. Snyder
Niles Bejerot
Charles E. Edwards
Food and Drug Administration
SmithKline & French Laboratories
Pfizer
Omaha
FDA
Miltown